Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.35 |
| ▸ | LSS | P48449 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27686879 | 0.93 | ALDH1A1 (0.46) | ALDH1A1TSHRKDM4ESMN1; SMN2DNM1 | |
| SCHEMBL28217870 | 0.79 | DNM1 (0.58) | ALDH1A1TSHRKDM4EDNM1LSS | |
| SCHEMBL26726911 | 0.74 | — | — | |
| SCHEMBL18892828 | 0.74 | — | — | |
| SCHEMBL28249124 | 0.72 | CA1 (0.30) | — | |
| SCHEMBL27812501 | 0.72 | CA1 (0.30) | — | |
| SCHEMBL27576105 | 0.72 | CA1 (0.30) | — | |
| Trimethylammonium SCHEMBL27834415 | 0.71 | CA1 (0.39) | TSHRDNM1 | |
| SCHEMBL530011 | 0.69 | ALDH1A1 (0.53) | ALDH1A1TSHRKDM4ESMN1; SMN2HRH3 | |
| Ammonia Solution, Strong SCHEMBL27711043 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116850119-B | Preparation method of telomerase composition and application of telomerase composition in hair conditioner for preventing alopecia | 上海联衡生物科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118518611-A | Rapid detection kit and method for 2' -fucosyllactose | 新镁(上海)生物技术有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-117836350-A | Polyalkylene oxide-containing compound | 株式会社日本触媒 | 2024-04-05 | — | — | CN | disclosed |
| CN-105647715-B | Detergent product | 宝洁公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-105055306-B | Stable multi-dose compositions comprising antibody and preservative | 诺沃—诺迪斯克有限公司 | 2019-10-01 | — | — | CN | disclosed |
| CN-109983110-A | Machine dishwashing detergent comprising copolymer | 科莱恩国际有限公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-105001333-B | Anti-human NKG2D antibodies and uses thereof | 诺沃—诺迪斯克有限公司 | 2019-05-17 | — | — | CN | disclosed |
| CN-109562182-A | Pharmaceutical preparation comprising cineole and Amoxicillin | 先进科学发展公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109557707-A | Liquid crystal display device | DIC株式会社 | 2019-04-02 | — | — | CN | disclosed |
| CN-104829720-B | KIR-BINDING AGENTS AND METHODS OF USING THE SAME | 诺和诺德公司 | 2019-01-01 | — | — | CN | disclosed |
| CN-101180081-A | Stabilized polypeptide formulations | NOVO NORDISK AS (DK) | 2008-05-14 | — | — | CN | disclosed |
| CN-101123992-A | Derivatives of insulinotropic agents conjugated with structurally well defined branched polymers | NOVO NORDISK AS (DK) | 2008-02-13 | — | — | CN | disclosed |
| CN-101052647-A | Novel peptide for treating obesity | NOVO NORDISK AS (DK) | 2007-10-10 | — | — | CN | disclosed |
| CN-101052650-A | Novel peptide for treating obesity | NOVO NORDISK AS (DK) | 2007-10-10 | — | — | CN | disclosed |
| CN-101052649-A | Peptides for the Treatment of Obesity | NOVO NORDISK AS (DK) | 2007-10-10 | — | — | CN | disclosed |
| CN-101052648-A | Novel peptides for the treatment of obesity | NOVO NORDISK AS (DK) | 2007-10-10 | — | — | CN | disclosed |
| CN-1950078-A | Use of GLP-1 agonists against drug-induced obesity | NOVO NORDISK AS (DK) | 2007-04-18 | — | — | CN | disclosed |
| CN-1909930-A | Transglutaminase mediated conjugation of peptides | NOVO NORDISK AS (DK) | 2007-02-07 | — | — | CN | disclosed |
| CN-1882357-A | Therapeutic use of factor XI | NOVO NORDISK HEALTHCARE AG (CH) | 2006-12-20 | — | — | CN | disclosed |
| CN-1535315-A | Compositions and methods for enhancing stress tolerance in plants | ����ֲ | 2004-10-06 | — | — | CN | disclosed |